- Home
- HSCS vs PALI Comparison
HSCS vs PALI Comparison
Compare HSCS & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PALI
- Stock Information
- Founded
- HSCS 2007
- PALI 1996
- Country
- HSCS United States
- PALI United States
- Employees
- HSCS N/A
- PALI N/A
- Industry
- HSCS Medical Specialities
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSCS Health Care
- PALI Health Care
- Exchange
- HSCS Nasdaq
- PALI Nasdaq
- Market Cap
- HSCS 2.8M
- PALI 3.2M
- IPO Year
- HSCS 2022
- PALI N/A
- Fundamental
- Price
- HSCS $3.30
- PALI $0.72
- Analyst Decision
- HSCS Strong Buy
- PALI Strong Buy
- Analyst Count
- HSCS 2
- PALI 2
- Target Price
- HSCS $13.00
- PALI $23.00
- AVG Volume (30 Days)
- HSCS 8.7K
- PALI 71.2K
- Earning Date
- HSCS 03-13-2025
- PALI 05-12-2025
- Dividend Yield
- HSCS N/A
- PALI N/A
- EPS Growth
- HSCS N/A
- PALI N/A
- EPS
- HSCS N/A
- PALI N/A
- Revenue
- HSCS N/A
- PALI N/A
- Revenue This Year
- HSCS N/A
- PALI N/A
- Revenue Next Year
- HSCS N/A
- PALI N/A
- P/E Ratio
- HSCS N/A
- PALI N/A
- Revenue Growth
- HSCS 261.17
- PALI N/A
- 52 Week Low
- HSCS $2.36
- PALI $0.60
- 52 Week High
- HSCS $13.50
- PALI $9.09
- Technical
- Relative Strength Index (RSI)
- HSCS 55.49
- PALI 45.23
- Support Level
- HSCS $2.97
- PALI $0.65
- Resistance Level
- HSCS $3.83
- PALI $0.77
- Average True Range (ATR)
- HSCS 0.28
- PALI 0.05
- MACD
- HSCS 0.06
- PALI 0.02
- Stochastic Oscillator
- HSCS 56.20
- PALI 70.59
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.